Booking 144.53% Gains — And Two New Options Recommendations

Nicholas Vardy

Nicholas Vardy has a unique background that has proven his knack for making money in different markets around the world.
Overall, last week was a down one for the markets, with the Dow Jones falling 0.99%, and the S&P 500 slipping 0.58%. The MSCI Emerging Markets Index also took it on the chin ending the week 3.08% lower.
 
In contrast, your Bull Market Alert portfolio had a mostly profitable, if volatile week. 
 
Pharmacyclics Inc. (PCYC) took off like a rocket, soaring 15.93%. This allowed you to book a double-digit gain of 71.53% and a triple-digit gain of 137.23%  on the options I recommended just last Monday. 
 
3D Systems Corp. (DDD) also jumped 6.96%. With your options up 43.75%, get ready to take your first round of option profits soon. You were, however, stopped out of Liquidity Management (LQDT) at a loss.
 
This week’s Bull Market Alert recommendations all relate to specific options on your current holdings.
  1. Sell your remaining Pharmacyclics Inc. (PCYC) options to lock in a 144.53% gain. After last week’s run, the stock is extremely overbought, and the options are overvalued. With an $80 price target on the stock, I expect to recommend additional options on this pick as soon as the stock takes a breather from its current relentless run. Raise your stop on the stock to $35.00.
  2. With Monster Beverage Corp (MNST) pulling back last week, I’m recommending that you take advantage of this opportunity to buy the September $75 call options (MNST120922C00075000). You’ve already made double and triple-digit option profits on this pick, and I think the current correction in the stock offers you another bite at the apple.
  3. Mellanox Technologies, Ltd. (MLNX) got off to a solid start in its first week in the Bull Market Alert portfolio, with the stock rising 3.90%. I did not recommend options on MLNX last week, as I felt they were overvalued. With the stock pulling back off of its highs, this is a good time to bet on further upside in the stock. So buy the September $75 call options (MLNX120922C00075000) for potentially big gains in this leader in cloud computing. 
Exclusive  Serving Up Apple on Fine China; Great Rotation, Take Two; Red Light, Green Light -- Global Markets Play the Game Ahead of Fed

Portfolio Update

Bank of Ireland (IRE) rose 1.75% last week. Billionaire investor and IRE shareholder Wilbur Ross is set to join IRE’s board of directors. This move will likely allow Ross to take a more “hands-on”  approach to his investment and have a positive effect on his investment, and yours. Trading above its 50 day moving average,  IRE is a BUY.
 
National Bank of Greece SA (NBG) gave back just 1.65% of its stellar fifty percent gain from the previous week. NBG is within striking distance of the 50-day moving average, falling just one penny short on Friday. NBG is a HOLD at the moment, but could change to a “buy” early this week.
 
Monster Beverage Corp. (MNST) lost 6.40%. MNST is currently a member of the S&P Midcap 400 Index, but Standard & Poor’s will add Monster Beverage Corp. to the S&P 500 Index this week. MNST is a BUY.
 
Novo Nordisk A/S (NVO) rose 2.34% last week. NVO will begin phase 3 testing of its diabetes drug Semaglutide. Novo Nordisk is developing Semaglutide for the control of type-2 diabetes, and seeing great promise in allowing patients to administer only a single weekly dose. NVO is a HOLD.
 
3D Systems Corp. (DDD) added 6.96%. DDD will demonstrate its newest 3D printer this week at the International Society for Technology in Education convention. The ProJet 1500 color 3D printer costs less than $4,000 and allows on-the-spot printing of durable parts that feature a smooth-surface finish. A top bet on the the 3D printing revolution, DDD is a BUY.
 
Pharmacyclics Inc. (PCYC) jumped 15.93% over the past five trading days. The stock maintained its remarkable momentum, PCYC continued to benefit from the recent positive clinical-trial report for its drug “ibrutinib”. PCYC hit new 52-week highs all last week on strong volume, and also generated generated on of our quickest ever triple-digit option gains. PCYC is a BUY. Raise your stop to $35.00.
 
Mellanox Technologies, Ltd. (MLNX) gained 3.90% during its first week in your portfolio. Analyst firm Wunderlich Securities reaffirmed its “Buy” rating on MLNX this week and raised its price target to a hefty $85. This price level is more than 22% above Friday’s closing price. MLNX is a BUY.
 

Like This Article?
Now Get Our FREE Special Report:
Alternative Investing: Investing in Timber

Stock Investor editor Paul Dykewicz reveals why investing in timber may be one of the best long-term portfolio strategies you'll find today.

Get Access to the Report, 100% FREE


img
previous article

Yesterday was a lousy day in the markets. Yet last week's pick, Pharmacyclics Inc. (PCYC), continues its remarkable ride, soaring 4.44% even as the S&P 500 tumbled 2.23%.
 
With your August $43 calls up 137.23%, sell half of your options to lock in your quickest triple-digit winner this year.
 
With PCYC's stock now up 15.76% since I recommended it on June 11, hold on to the stock and the rest of the options for now.

PREMIUM SERVICES FOR INVESTORS

Dr. Mark Skousen

Named one of the "Top 20 Living Economists," Dr. Skousen is a professional economist, investment expert, university professor, and author of more than 25 books.

Product Details

LEARN MORE HERE

Bryan Perry

A former Wall Street financial advisor with three decades' experience, Bryan Perry focuses his efforts on high-yield income investing and quick-hitting options plays.

Product Details

LEARN MORE HERE

Jim Woods

Jim Woods has over 20 years of experience in the markets from working as a stockbroker,
financial journalist, and money manager. As well as a book author and regular contributor to
numerous investment websites, Jim is the editor of:

Product Details

LEARN MORE HERE

Bob Carlson

Bob Carlson provides independent, objective research covering all the financial issues of retirement and retirement planning. In addition, Bob serves as Chairman of the Board of Trustees of the Fairfax County (VA) Employees’ Retirement System, which has over $2.8 billion in assets.

Product Details

LEARN MORE HERE

Mike Turner

Mike Turner’s financial, mathematical, computer science and engineering background serves as the foundation for his disciplined, rules-based approach to trading. Mike’s three services include:

Product Details

LEARN MORE HERE

Hilary Kramer

Hilary Kramer is an investment analyst and portfolio manager with 30 years of experience on Wall Street. Since 2010, Hilary's financial publications have provided stock analysis and investment advice to her subscribers:

Product Details

LEARN MORE HERE

DividendInvestor.com

Used by financial advisors and individual investors all over the world, DividendInvestor.com is the premier provider and one-stop shop for dividend information and research.

Product Details

Popular tools include our proprietary Dividend Calendar, Dividend Calculator, Dividend Score Card, and many more.

LEARN MORE HERE